Tata 1mg company logo

Tata 1mg Share Price

DMAT

PRIVATE LIMITED

Price Chart

High

₹1,08,199

Low

₹1,810.2

Return

5.00%

Buy Sell Tata 1mg Unlisted Shares

As of November 20, 2026, Tata 1mg Technologies Private Limited Unlisted Shares are available at ₹108,199.00 per share, with a face value of ₹1.00 per share, a 52-week high of ₹108,199.00 and a 52-week low of ₹103,047.00. The minimum lot size is None shares, and the shares can be held in dematerialised form through NSDL and CDSL.

ISIN

info icon

INE0BLN01018

Face Value

info icon

1

Total Shares

info icon

8,48,338

Market Cap

info icon

9,178.93 Cr

Sector

info icon

Technology

Sub-sector

info icon

Health Tech

Category

info icon

Unicorn

About Tata 1mg

Company Overview:

  • ​Tata 1mg is a leading healthcare platform in India, providing a wide range of services, including online pharmacy, diagnostics, e-consultation, and health content. The company was initially focused on providing information on medicines and helping people use their medicines effectively and safely. In 2016, 1mg launched its online pharmacy business, and in 2017, it launched its diagnostics business.
  • Tata 1mg offers a wide range of medicines and healthcare products, including prescription medicines, over-the-counter medicines, and health supplements. It also offers a wide range of diagnostic tests, including blood tests, urine tests, and imaging tests. Tata 1mg's e-consultation service allows patients to book appointments online and consult with doctors from a variety of specialties over video calls or chat. The company also publishes a health content library that includes articles, videos, and infographics on a wide range of health topics, such as disease prevention, treatment options, and healthy living.
  • Tata 1mg is a subsidiary of Tata Digital Limited, a subsidiary of Tata Sons, which is part of the Tata Group, one of India's largest and most respected conglomerates.  In December 2020, Tata Digital acquired a majority stake in 1mg, leading to the rebranding of the platform as "Tata 1mg."
  • Tata 1mg has a customer base is over 10 million, with over 1,00,000 medicines and healthcare products on its platform. The company also has more than 10,000 partner pharmacies across India. Also, the company offers a wide range of diagnostic tests, including blood tests, urine tests, and imaging tests. 
  • 1mg was founded in 2015 by Prashant Tandon, Gaurav Agarwal, and Vikas Chauhan. It initially started as HealthKartPlus, a platform that provided information about medicines and their substitutes.  HealthKartPlus later rebranded itself as "1mg" to emphasize its focus on providing healthcare solutions, including medicines, health information, and diagnostic services.
  •  Tata 1mg is committed to making healthcare accessible, understandable, and affordable for all Indians. The company is playing a leading role in the transformation of the Indian healthcare sector through its innovative and customer-centric services. Also, has been recognized for its innovative healthcare services and has won numerous awards, including the "Best Healthcare Company" award at the India Digital Awards 2022.
  • ​Tata 1mg has a strong presence in over 1,000 cities in India. Its registered office is located at Level 3, Vasant Square Mall, Pocket V, Sector B, Vasant Kunj New Delhi South Delhi DL 110070.

Want to See a Detailed Investment Analysis?

Explore in-depth financial analysis, performance metrics, and key disclosures.

Tata 1mg Media

Khyaal and Tata 1mg join hands to empower Senior citizens with Holistic Healthcare Solutions

Khyaal and Tata 1mg join hands to empower Senior citizens with Holistic Healthcare Solutions

18 Sep 2023

• Your Story

Health financing startup Kenko signs partnership with Tata 1mg

Health financing startup Kenko signs partnership with Tata 1mg

21 Aug 2023

• Mint

Tata 1mg revenue up to ₹1,627 cr, loss widens to ₹1,254 cr

Tata 1mg revenue up to ₹1,627 cr, loss widens to ₹1,254 cr

08 Aug 2023

• The Business Line

Frequently Asked Question (FAQs)

The annual report of Tata 1mg Ltd is available in the annual report section.
Lock-in period of Tata 1mg Unlisted Shares depends upon category of investors.
• 1. Venture Capital Funds or Alternate Investment Fund of Category -I or II, or Foreign Venture Capital Investor - lock-in Period of 6 months from the date of acquisition of Tata 1mg Unlisted Shares.
• 2. Other Investors (include Retail, HNIs or Body Corporate) lock-in Period of 6 months from the date of listing of IPO of Tata 1mg Unlisted Shares.
This new SEBI rule was introduced in the month of August-2021, wherein the SEBI has reduced the lock-in period previously from 1 year to 6 months to encourage more and more funds to be invested in startups which are going to public or IPO in near future. Reduction of lock-in is seen as big step and after that many PMS funds are advising their clients to invest in Pre-IPO shares to get the benefit of early stage investment.
Yes, buying and selling of unlisted shares in India is 100% legal.

Tata 1mg

₹ 1,08,199